Emily Kennedy

Emily Kennedy currently serves as a RADx Program Facilitator at the National Institutes of Health, where responsibilities include co-developing programmatic infrastructure for COVID-19 diagnostic testing, managing assessments of emerging variants' impacts on diagnostics, and facilitating commercial partnerships. Prior to this, Emily co-founded and was CEO of Hedgemon, where significant fundraising and business development efforts aimed at commercializing patented impact protection technology took place. Experience also includes roles as Director of External Relations at the University of Akron's Biomimicry Research and Innovation Center, Senior Consultant at Great Lakes Biomimicry, and Biomimicry Fellow at GOJO Industries, with a focus on innovation and education in biomimicry. Emily's academic credentials include a Ph.D. in Integrated Bioscience from the University of Akron and a Bachelor's Degree in International Relations from Colgate University.